HR+ BC, in contrast, generally exhibits lower immune infiltration but still experiences NK cell suppression via TGF-β, IL-6, CCL2, and estrogen signaling, each of which reduces NK cell cytotoxicity and infiltration [86, 87]. The gene discussed is IL6; the disease is breast cancer.